Cigarette smoke components modulate the MR1-MAIT axis

J Exp Med. 2025 Feb 3;222(2):e20240896. doi: 10.1084/jem.20240896. Epub 2025 Jan 17.

Abstract

Tobacco smoking is prevalent across the world and causes numerous diseases. Cigarette smoke (CS) compromises immunity, yet little is known of the components of CS that impact T cell function. MR1 is a ubiquitous molecule that presents bacterial metabolites to MAIT cells, which are highly abundant in the lungs. Using in silico, cellular, and biochemical approaches, we identified components of CS that bind MR1 and impact MR1 cell surface expression. Compounds, including nicotinaldehyde, phenylpropanoid, and benzaldehyde-related scaffolds, bound within the A' pocket of MR1. CS inhibited MAIT cell activation, ex vivo, via TCR-dependent and TCR-independent mechanisms. Chronic CS exposure altered MAIT cell phenotype and function and attenuated MAIT cell responses to influenza A virus infection in vivo. MR1-deficient mice were partially protected from the development of chronic obstructive pulmonary disease (COPD) features that were associated with CS exposure. Thus, CS can impair MAIT cell function by diverse mechanisms, and potentially contribute to infection susceptibility and disease exacerbations.

MeSH terms

  • Animals
  • Cigarette Smoking / adverse effects
  • Female
  • Histocompatibility Antigens Class I* / immunology
  • Histocompatibility Antigens Class I* / metabolism
  • Humans
  • Influenza A virus / immunology
  • Lung / immunology
  • Lung / metabolism
  • Lung / pathology
  • Lymphocyte Activation
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Minor Histocompatibility Antigens / genetics
  • Minor Histocompatibility Antigens / metabolism
  • Mucosal-Associated Invariant T Cells* / immunology
  • Mucosal-Associated Invariant T Cells* / metabolism
  • Orthomyxoviridae Infections / immunology
  • Pulmonary Disease, Chronic Obstructive / etiology
  • Pulmonary Disease, Chronic Obstructive / immunology
  • Pulmonary Disease, Chronic Obstructive / metabolism
  • Pulmonary Disease, Chronic Obstructive / pathology
  • Smoke / adverse effects
  • Tobacco Products / adverse effects

Substances

  • Histocompatibility Antigens Class I
  • Minor Histocompatibility Antigens
  • Smoke
  • MR1 protein, human
  • Mr1 protein, mouse